A detailed history of Thrivent Financial For Lutherans transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 39,098 shares of PTCT stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,098
Holding current value
$1.78 Million
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$30.39 - $37.66 $1.19 Million - $1.47 Million
39,098 New
39,098 $1.45 Million
Q4 2023

Feb 14, 2024

BUY
$18.07 - $29.37 $611,705 - $994,233
33,852 New
33,852 $933,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.25B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.